The Chemours Company Makes the 2017 Fortune 500 List Less Than Two Years After Its Spin-Off

WILMINGTON, Del., June 7, 2017 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, today announced that in less than two years after its 2015 spinoff it has been named for the first time to the Fortune 500 list of the nation's largest corporations.  With $5.5B in revenues in 2016, Chemours ranks #482 on the overall list revealed today via Fortune Magazine.

"We're so proud to see our name on this coveted list less than two years after becoming a public company and overcoming some real challenges at our start," said Mark Vergnano, president and CEO, adding, "This honor was not given; it was earned. It is a testament to the flawless execution by our workforce of our five-point transformation plan, and demonstrates the strides that our company has made to become a stronger, healthier, and more stable company."

Chemours' transformation plan, launched in 2015, has served as the company's roadmap to dramatic fiscal and organizational improvements. Its focus continues to be reducing structural costs, growing market positions, optimizing the company's portfolio, refocusing investments, and transforming the company's culture.

Said Vergnano, "While it's affirming to make the Fortune 500 list, we realize we have to keep working hard to stay on the list, to bring our transformation plan to a successful completion by the end of 2017, and to realize our full potential as we continue on our journey of growth." 

About The Chemours Company

The Chemours Company (NYSE: CC) helps create a colorful, capable and cleaner world through the power of chemistry.  Chemours is a global leader in titanium technologies, fluoroproducts and chemical solutions, providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations.  Chemours ingredients are found in plastics and coatings, refrigeration and air conditioning, mining and general industrial manufacturing.  Our flagship products include prominent brands such as Teflon™, Ti-Pure™, Krytox™, Viton™, Opteon™, Freon™ and Nafion™.  Chemours has approximately 7,000 employees and 26 manufacturing sites serving approximately 4,000 customers in North America, Latin America, Asia-Pacific and Europe.  Chemours is headquartered in Wilmington, Delaware and is listed on the NYSE under the symbol CC.  For more information please visit

Forward-Looking Statements

This press release contains forward-looking statements, within the meaning of the federal securities laws, that involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. The words "believe," "expect," "anticipate," "plan," "estimate," "target," "project" and similar expressions, among others, generally identify "forward-looking statements," which speak only as of the date the statements were made. These forward-looking statements address, among other things, the offering, our agreement with DuPont relating to the MDL Settlement, resolution of environmental liabilities, litigation and other contingencies, anticipated future operating and financial performance, business plans and prospects, that are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Forward-looking statements are based on certain assumptions and expectations of future events which may not be accurate or realized. Forward-looking statements also involve risks and uncertainties, many of which are beyond Chemours' control. Additionally, there may be other risks and uncertainties that Chemours is unable to identify at this time or that Chemours does not currently expect to have a material impact on its business. Factors that could cause or contribute to these differences include whether the offering is completed and other risks, uncertainties and other factors discussed in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the year ended December 31, 2016. Chemours assumes no obligation to revise or update any forward-looking statement for any reason, except as required by law.


Alvenia Scarborough
Director of Brand Marketing and Corporate Communications
[email protected] 

Alisha Bellezza
Treasurer and Director of Investor Relations
[email protected]

To view the original version on PR Newswire, visit:

SOURCE The Chemours Company